Symptomatic Response to Antiarrhythmic Drug Therapy Is Modulated by a Common Single Nucleotide Polymorphism in Atrial Fibrillation
- 7 August 2012
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 60 (6), 539-545
- https://doi.org/10.1016/j.jacc.2012.01.070
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (U19 HL65962, HL092217)
This publication has 33 references indexed in Scilit:
- Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specificationProceedings of the National Academy of Sciences of the United States of America, 2010
- Common variants in KCNN3 are associated with lone atrial fibrillationNature Genetics, 2010
- Variation in the 4q25 Chromosomal Locus Predicts Atrial Fibrillation After Coronary Artery Bypass Graft SurgeryCirculation: Cardiovascular Genetics, 2009
- Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillationJournal of Molecular and Cellular Cardiology, 2009
- A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic strokeNature Genetics, 2009
- Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestryNature Genetics, 2009
- Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillationEuropean Heart Journal, 2008
- Atrial Natriuretic Peptide Frameshift Mutation in Familial Atrial FibrillationNew England Journal of Medicine, 2008
- Cardiac Sodium Channel ( SCN5A ) Variants Associated with Atrial FibrillationCirculation, 2008
- Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillationHeart Rhythm, 2007